Addenbrooke's Cognitive Examination - III (ACE-III)
This screening tool helps clinicians detect early signs of dementia and cognitive decline. It assesses memory, attention, and language skills to support accurate diagnosis and care.
Addenbrooke's Cognitive Examination - III (ACE-III)
Addenbrooke's Cognitive Examination - III (ACE-III) screens for cognitive impairment and dementia. It evaluates attention, memory, fluency, language, and visuospatial skills. This reliable test helps clinicians identify deficits early, providing a detailed profile of a patient's mental function.
Category
Disease
Source
What is Addenbrooke's Cognitive Examination - III (ACE-III)
The Addenbrooke's Cognitive Examination - III (ACE-III) is a trusted screening tool that helps clinicians detect signs of cognitive impairment and dementia. Replacing the older ACE-R, this detailed assessment evaluates five primary cognitive domains to provide a clear and thorough snapshot of a patient's mental function. It specifically checks attention, memory, fluency, language, and visuospatial skills. The total score is out of 100, where higher numbers suggest better cognitive health, and specific thresholds help identify potential issues like Alzheimer's disease or other deficits. Clinicians can administer the test in roughly 15 to 20 minutes, making it practical for busy clinics. It is available in multiple languages and is free for clinical use. This flexibility allows healthcare teams to track changes over time and plan better support for patients facing memory loss.
The Addenbrooke's Cognitive Examination III can be scored using two main evaluation approaches. 1. Total Score: Clinicians sum points from Attention, Memory, Fluency, Language, and Visuospatial tasks for a maximum of 100. Higher numbers mean better function. 2. Cutoff Analysis: A total score below 88 usually points to cognitive impairment, while scores under 82 strongly suggest dementia. It's important to review individual domain subscores too, as this helps spot specific weaknesses and tracks a patient's progress in clinical settings.
Advantages
Enables precise identification of patient health status.
.svg){kind=icon}
Applicable across multiple diseases and conditions.
.svg){kind=icon}
Streamlines research data gathering process.
.png){kind=icon}
Related Instruments
Screens for neuropathic pain components.
Predicts long-term disability risk in musculoskeletal pain.
Assesses symptoms and function in lumbar spinal stenosis.
Streamline Addenbrooke's Cognitive Examination - III assessments with WeGuide
Support Your patient in no time - all under your own brand
Our platform combines the knowledge of 100+ digital health solutions built, letting you easily build your patient engagement app for research or clinical use. Collect PROMs, support patients on waiting lists, or gather vital signs data. This is how:
Learn More.png){kind=icon}
Program Builder
.png)
.png){kind=icon}
Whitelabelling
.svg)
.svg)
.png){kind=icon}
Turn on components, dependent on your usecase
.svg)
.png){kind=icon}
Support The Full Journey
.png)
.png)
%20(1).png)
.png)
It’s your turn
Every WeGuide project, saves researchers and clinicians - 9 months and $450,000 - creating impactful digital health solutions.
